Prevention of central line-associated bloodstream infections in hemodialysis patients

Infection Control and Hospital Epidemiology

Volumn 33, Issue 9, 2012, Pages 936-944

  Boyce, John M ^a,b  

^a HOSPITAL OF SAINT RAPHAEL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMIKACIN; ANTIBIOTIC AGENT; BACITRACIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CHLORHEXIDINE; CIPROFLOXACIN; CITRATE TRISODIUM; GENTAMICIN; GRAMICIDIN; HEPARIN; METHYL PARABEN; MINOCYCLINE; POLYMYXIN B; POVIDONE IODINE; PROPYL PARABEN; TAUROLIDINE; VANCOMYCIN;

ALLERGIC REACTION; ANTIBIOTIC RESISTANCE; ANTISEPSIS; BACTEREMIA; BANDAGE; BLEEDING; CATHETER INFECTION; DIALYSIS CATHETER; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HOSPITAL HYGIENE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MEDICAL PRACTICE; MEDICARE; MORBIDITY; MORTALITY; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; STAPHYLOCOCCUS INFECTION;

AMBULATORY CARE; ANTI-INFECTIVE AGENTS, LOCAL; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; HUMANS; INFECTION CONTROL; RENAL DIALYSIS; UNITED STATES;

EID: 84864956104     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/667369     Document Type: Review

References (69)

1. Centers for Disease Control and Prevention. Vital signs: central line-associated bloodstream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011;60: 243-248.
2. Kallen AJ, Patel PR, O'Grady NP. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis 2010;51:335-341.
3. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 annual data report. Am J Kidney Dis 2011;57(suppl 1): e1-e526.
4. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004;44:779-791.
5. Allon M, Depner TA, Radeva M, et al; HEMO Study Group. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol 2003;14:1863-1870.
6. Pastan S, Soucie JM, McClellan VVM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002;62:620-626.
7. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002;51(RR-10):1-26.
8. Collins AJ, Foley RN, Herzog C, et al. Excerpts from the US Renal Data System 2009 annual data report. Am J Kidney Dis 2010;55(suppl 1):S1-S420.
9. Inrig JK, Reed SD, Szczech LA, et al. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol 2006;1:518-524.
10. Klevens RM, Edwards JR, Andrus ML, Peterson KD, Dudeck MA, Horan TC; NHSN Participants in Outpatient Dialysis. Dialysis surveillance report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial 2008;21:24-28.
11. Engemann JJ, Friedman JY, Reed SD, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005;26:534-539.
12. Ramanathan V, Chiu EJ, Thomas JT, Khan A, Dolson GM, Darouiche R. Healthcare costs associated with hemodialysis catheter-related infections: a single-center experience. Infect Control Hosp Epidemiol 2007;28:606-609.
13. Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int 2011; 79:587-598.
14. Centers for Disease Control and Prevention (CDC). CDC's Core Interventions for Dialysis BSI Prevention. http://www.cdc.gov/dialysis/pdfs/collaborative/dialysis-core-interventions-rev_08_23_11.pdf. Atlanta: CDC, 2011. Accessed July 7, 2012.
15. Allon M, Dinwiddie L, Lacson E Jr, et al. Medicare reimbursement policies and hemodialysis vascular access outcomes: the need for change. J Am Soc Nephrol 2011;22:426-430.
16. National Kidney Foundation. K/DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2001;37(suppl 1): S137-S181.
17. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-2732.
18. O'Grady NP, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:e162-e193.
19. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003;14:169-179.
20. Battistella M, Bhola C, Lok CE. Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report. Am J Kidney Dis 2011;57:432-441.
21. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47:83-93.
22. Labriola L, Crott R, Jadoul M. Preventing haemodialysis cancerrelated bacteraemia with an antimicrobial lock solution: a metaanalysis of prospective randomized trials. Nephrol Dial Transplant 2008;23:1666-1672.
23. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A metaanalysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 2008;51: 233-241.
24. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008;148:596-605.
25. Snaterse M, Ruger W, Scholte op Reimer WJM, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 2010;75:1-11.
26. Winnett G, Nolan J, Miller M, Ashman N. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheterrelated bacteraemia. Nephrol Dial Transplant 2008;23:3592-3598.
27. Abbas SA, Haloob IA, Taylor SL, et al. Effective antimicrobial locks for tunneled hemodialysis catheters on bloodstream in fection and bacterial resistance: a quality improvement report. Am J Kidney Dis 2009;53:492-502.
28. Chow KM, Poon YL, Lam MP, Poon KL, Szeto CC, Li PKT. Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients. Hong Kong Med J 2010; 16:269-274.
29. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010;5:1799-1804.
30. Filiopoulos V, Hadjiyannakos D, Koutis I, et al. Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am J Nephrol 2011;33:260-268.
31. Power A, Duncan N, Singh SK, et al. Sodium citrate versus heparin catheter locks for cuffed central vein as catheters: a single-center randomized controlled trial. Am J Kidney Dis 2009; 53:1034-1041.
32. Solomon LR, Cheesbrough JS, Ebah L, et al. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 2010;55:1060-1068.
33. Campos RP, do Nascimento MM, Chula DC, Riella MC. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol 2011;22:1939-1945.
34. Hemmelgarn BR, Moist LM, Lok CE, et al; Prevention of Dialysis Catheter Lumen Occlusion with rt-PA versus Heparin (PreCLOT) Study Group. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011;364:303-312.
35. Maki DG, Ash SR, Winger RK, Lavin P; AZEPTIC Trial Investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med 2011;39:613-620.
36. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 2012;59:102-107.
37. Cooper RI, Saad TF. Prevention of bacteremia in patients with tunneled cuffed "permanent" hemodialysis catheters using gentamicin catheter packing [abstract]. J Am Soc Nephrol 1999;10: 203A.
38. Ash S, Mankus R, Sutton J, et al. Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 2000;4:22-31.
39. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002;13:2133-2139.
40. Pervez A, Ahmed M, Ram S, et al. Antibiotic lock technique for prevention of cuffed tunneled catheter associated bacteremia. J Vasc Access 2002;3:108-113.
41. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36:1539-1544.
42. Betjes MG, van Agteren M. Prevention of dialysis catheterrelated sepsis with a citrate-taurolidine-containing block solution. Nephrol Dial Transplant 2004;19:1546-1551.
43. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004;66:801-805.
44. Dogra G, White L, Herson H, et al. Prevention of tunneled hemodialysis catheter-related infections using low concentration gentamicin and citrate [abstract]. Nephrology 2004;9(suppl 1): S13A.
45. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) contemporary hemodialysis access. Infect Control Hosp Epidemiol 2005;26:520-524.
46. Weijmer MC, van den Dorpel MA, Van de Ven PJ, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-blocking solution in hemodialysis patients. J Am Soc Nephrol 2005;16:2769-2777.
47. Lambie SH, Hulme LJ, Taal M, Fluck RJ, McIntyre CW. Prospective study of gentamicin locking of tunneled dialysis catheters: the effect on infection rates and CRP. Kidney Int 2005;67: 378.
48. Geron R, Tanchilevski O, Kristal B. Catheter lock solution-taurolock for prevention of catheter-related bacteremia in hemodialysis patients. Harefuah 2006;145:881-884.
49. Kim SH, Song KI, Chang JW, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 2006;69:161-164.
50. Nori US, Manoharan A, Yee J, Besarab A. Comparison of lowdose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 2006;48:596-605.
51. Saxena AK, Panhotra BR, Sundaram DS, et al. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 2006;70:1629-1635.
52. Zhang P, Zhang W, He Q, et al. A randomized controlled study and prevention of cuff-tunneled catheter related bacteremia with gentamicin-heparin lock solution: the metaphase result [abstract]. J Am Soc Nephrol 2006;17:592A.
53. Fluck RJ, McIntyre CW, Taal M. A one-year experience single center with antibiotic locking for tunneled venous catheters [abstract]. J Am Soc Nephrol 2006;17:591A.
54. D'Avella J, Qamar A, McDaniel A, Robbins K, Cooper B. A randomized trial of hypertonic saline and heparin lock solution in the prevention of hemodialysis catheter related bacteremia [abstract]. J Am Soc Nephrol 2007;18:460A.
55. Duncan N, Singh S, Amao M, et al. A single centre randomised controlled trial of sodium citrate versus heparin lying locks for cuffed central venous catheters [abstract]. J Am Soc Nephrol 2005;16:451A.
56. Al-Hwiesh AK, Abdul-Rahman IS. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin gentamicin. Saudi J Kidney Dis Transplant 2007;18: 239-247.
57. Feely T, Copley A, Bleyer AJ. Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients. Am J Nephrol 2007;27:24-29.
58. Onder AM, Chandar J, Billings A, et al. Prophylaxis of catheterrelated bacteremia using tissue plasminogen activator-tobramycin locks. Pediatr Nephrol 2009;24:2233-2243.
59. Venditto M, du Montcel ST, Robert J, et al. Effect of catheterlock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purif 2010;29:268-273.
60. Fernandez-Gallego J, Martin M, Gutierrez E, et al. Prophylaxis with gentamicin locking of chronic tunneled central venous catheters does not cause bacterial resistance. Nefrologia 2011;31: 308-312.
61. Chaudhry M, Bhola C, Joarder M, et al. Seeing eye to eye: the key to reducing catheter use. J Vasc Access 2011;12:120-126.
62. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002;136: 792-801.
63. Wall RJ, Ely EW, Elasy TA, et al. Using real time process measurements to reduce catheter related bloodstream infections in the intensive care unit. Qual Saf Health Care 2005;14:295-302.
64. Annigeri R, Conly J, Vas S, et al. Emergence of mupirocinresistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001;21:554-559.
65. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002;39:337-341.
66. Johnson DW, van Eps C, Mudge DW, et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2012;16: 1456-1462.
67. Boyce JM, Pittet D; Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. MMWR Recomm Rep 2002;51(RR-16):1-45.
68. World Health Organization (WHO). WHO Guidelines for Hand Hygiene in Health Care. http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf. Geneva: WHO, 2009. Accessed July 7, 2012.
69. Saxena AK, Panhotra BR, Sundaram DS, et al. Enhancing the survival of tunnelled hemodialysis catheters using an antibiotic lock in the elderly: a randomized, double-blind clinical trial. Nephrology 2006;11:299-305.